Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 6/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.34 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21704887 | 0.92 | CYP1A2 (0.36) | CYP1A2CYP3A4CYP2C9CYP2C19ESR1 | |
| SCHEMBL21705051 | 0.88 | GPR84 (0.35) | CYP1A2CYP3A4CYP2C9CYP2C19ESR1 | |
| SCHEMBL21704892 | 0.87 | CYP1A2 (0.33) | CYP1A2CYP3A4CYP2C9CYP2C19ESR1 | |
| SCHEMBL23081347 | 0.85 | CYP1A2 (0.33) | CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL21705050 | 0.83 | ADORA2A (0.32) | CYP1A2ESR1ESR2 | |
| SCHEMBL21699099 | 0.83 | ESR1 (0.32) | ESR1ESR2 | |
| SCHEMBL21704897 | 0.81 | ESR1 (0.35) | CYP1A2ESR1ESR2AHR | |
| SCHEMBL21705107 | 0.81 | CYP1A2 (0.34) | CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL21704881 | 0.80 | GPR84 (0.37) | CYP1A2CYP3A4CYP2C9CYP2C19AHR | |
| SCHEMBL21705078 | 0.80 | ABCG2 (0.34) | CYP1A2CYP3A4CYP2C9CYP2C19ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370733-B2 | Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object | CANON KABUSHIKI KAISHA (JP) | 2022-06-28 | — | — | US | disclosed |
| US-20200048171-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT | CANON KABUSHIKI KAISHA (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048171-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT | OCIAD1, L1CAM, SPIN4 | CYP1A2 1327/4885CYP3A4 303/4885CYP2C9 1021/4885 |
| US-11370733-B2 | Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object | OCIAD1, L1CAM, SPIN4 | CYP1A2 1327/4885CYP3A4 303/4885CYP2C9 1021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.